SS 14 - Pediatric Cancer 1: Better Data = Better Outcomes: Prospective Trials in Pediatric Oncology

Presentations

• 08:00am - 08:10am PT

  10-Year Neuropsychological and QoL Outcomes in Pediatric Brain Tumor Survivors: A Comparison of Photon and Proton Cohorts

  Speaker: Torunn Yock, MD, FASTRO, MCH - Massachusetts General Hospital, Boston
• 08:00am - 09:00am PT

  Pediatric Cancer 1: Better Data = Better Outcomes: Prospective Trials in Pediatric Oncology

  Speaker: Nicole Larrier, MD, MS - Duke University Medical Center, Durham
• 08:00am - 09:00am PT

  Pediatric Cancer 1: Better Data = Better Outcomes: Prospective Trials in Pediatric Oncology

  Speaker: Daniel Indelicato, MD, FASTRO - University of Florida Department of Radiation Oncology, Jacksonville
• 08:10am - 08:20am PT

  Growth Outcomes Following Vertebral Body Sparing Proton CSI for Pediatric Brain Tumors: A Multicenter, Combined Prospective - Retrospective Cohort Study

  Speaker: Myrsini Ioakeim-Ioannidou, MD - Massachusetts General Hospital, Boston
• 08:20am - 08:30am PT

  Low Rates of Marginal Failure in Pediatric Patients Treated with Pencil Beam Scanning Proton Therapy: Results from a Single Institution Phase IV Surveillance Trial

  Speaker: John Roubil, MD - Massey Cancer Center, Richmond
• 08:30am - 08:40am PT

  Characterizing Radiation Target Volumes and Patterns of Failure in Pediatric Neuroendocrine Tumors Using ⁶⁸Ga DOTA-Octreotate PET/CT

  Speaker: Elizabeth McKone, MD - Mayo Clinic Rochester, Rochester
• 08:40am - 08:50am PT

  A Phase IV Surveillance Trial of Pencil Beam Scanning Proton Therapy in Children

  Speaker: John Lucas, MD, MS - St. Jude Childrens Research Hospital, Memphis
• 08:50am - 09:00am PT

  Discussant

  Speaker: Dana Casey, MD - University of North Carolina at Chapel Hill School of Medicine, Chapel Hill